Thatchawan Thanasupawat

Department of Human Anatomy and Cell Sciences, University of Manitoba

Research Area

Biography

Thatchawan Thanasupawat has not added Biography.
If you are Thatchawan Thanasupawat and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2024

Other Publications

Article	Year
INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours. Oncology reports\| PubMed ID: 23128569	2013
C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells. The Journal of pathology\| PubMed ID: 24014093	2013
Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells. Frontiers in endocrinology\| PubMed ID: 24723911	2014
Platinum (IV) coiled coil nanotubes selectively kill human glioblastoma cells. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 25680541	2015
RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer. Frontiers in endocrinology\| PubMed ID: 26322020	2015
PDK2-mediated alternative splicing switches Bnip3 from cell death to cell survival. The Journal of cell biology\| PubMed ID: 26416963	2015
Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells. British journal of pharmacology\| PubMed ID: 27443788	2017
Dovitinib enhances temozolomide efficacy in glioblastoma cells. Molecular oncology\| PubMed ID: 28500786	2017
C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma. Molecular oncology\| PubMed ID: 29949238	2018
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells. Molecular oncology\| PubMed ID: 30289618	2019
Emerging roles for the relaxin/RXFP1 system in cancer therapy. Molecular and cellular endocrinology\| PubMed ID: 30763603	2019
Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells. Molecular oncology\| PubMed ID: 33960104	2022
Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes. International journal of molecular sciences\| PubMed ID: 34502484	2021
Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes. International journal of molecular sciences\| PubMed ID: 36293188	2022
Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. International journal of molecular sciences\| PubMed ID: 36835656	2023
Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment. Biochimica et biophysica acta. Molecular basis of disease\| PubMed ID: 36921737	2023
Characterization of HMGA2 variants expands the spectrum of Silver-Russell syndrome. JCI insight\| PubMed ID: 38516887	2024
Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasis. bioRxiv : the preprint server for biology\| PubMed ID: 38529509	2024
C1QTNF Related protein 8 (CTRP8) is a marker of myeloid derived innate immune cell populations in the human breast cancer microenvironment. Biochemical pharmacology\| PubMed ID: 39542181	2024